Divis Laboratories Ltd | DIVI - PE Price to Earnings


Divis Laboratories Ltd reported 59.75 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Aurobindo Pharma 21.22 2.02 Mar/2026
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 59.75 6.76 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 19.37 7.21 Mar/2026
Lupin 17.5 2.33 Dec/2025
Moderna 27.22 14.51 Jun/2023
Organon & Co 3.75 0.87 Dec/2025
Revvity 30.79 19.08 Mar/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Tilray 11.56 80.19 Sep/2025
Viatris 14.61 4.21 Mar/2026